Mercer Global Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mercer Global Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Buy	+720	New	+$204K	﹤0.01%	3185
2026 Q1	–	Sell	-739	Closed	-$224K	–	3228
2025 Q4	$224K	Sell	739 -13	-2%	-$4.06K	﹤0.01%	2469
2025 Q3	$211K	Buy	+752	New	+$205K	﹤0.01%	2357
2024 Q1	–	Sell	-816	Closed	-$263K	–	2021
2023 Q4	$263K	Buy	+816	New	+$256K	﹤0.01%	1686
2022 Q3	–	Sell	-437	Closed	-$216K	–	1830
2022 Q2	$216K	Buy	+437	New	+$228K	﹤0.01%	1595
2022 Q1	–	Sell	-411	Closed	-$311K	–	1874
2021 Q4	$311K	Sell	411 -58	-12%	-$43.4K	﹤0.01%	1444
2021 Q3	$350K	Sell	469 -158	-25%	-$118K	﹤0.01%	1352
2021 Q2	$404K	Buy	627 +38	+6%	+$23.1K	﹤0.01%	1245
2021 Q1	$336K	Sell	589 -15	-2%	-$8.88K	﹤0.01%	1255
2020 Q4	$352K	Buy	+604	New	+$344K	﹤0.01%	1004

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mercer Global Advisors's BIO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 720 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #3185 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in BIO as recently as Q4 2025.

Mercer Global Advisors first reported a position in BIO in Q4 2020 and has held it in 10 quarters since. The position peaked at $404K in Q2 2021. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Mercer Global Advisors held 720 shares of Bio-Rad Laboratories Class A worth $211K as of Q2 2026.
Bio-Rad Laboratories Class A was a new Mercer Global Advisors position in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3185 holding.
Mercer Global Advisors first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and has held it in 10 quarters since.
Mercer Global Advisors's Bio-Rad Laboratories Class A position peaked at $404K in Q2 2021.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.